IGF::OT::IGF E-SELECTIN/AAV FOR THERAPEUTIC REVERSAL OF LIMB ISCHEMIA

VITA计划将为血管疾病、血栓性疾病和肺动脉高压领域的候选产品的早期翻译开发提供支持。拟议的项目领域可能包括外周动脉疾病、主动脉瘤和夹层、肺血管疾病、静脉和动脉血栓形成、血栓栓塞症和淋巴系统疾病。冠状动脉和颅内动脉疾病不包括在本计划的具体主题中。

The VITA Program will provide support for early-stage translational development of product candidates in the fields of vascular disorders, thrombotic diseases, and pulmonary hypertension. Proposed project areas of interest may include peripheral arterial disease, aortic aneurysms and dissections, pulmonary vascular disorders, venous and arterial thrombosis, thromboembolic disorders, and disorders of the lymphatic system. Not included as specific topics in this program are diseases of the coronary and intracranial arteries.